CORDIS US CORP.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.2M
Doctors Paid
3,284
Transactions
7,166
2024 Total
$1.5M
Payment Breakdown by Category
Consulting$2.6M (41.9%)
Research$2.4M (37.9%)
Food & Beverage$214,182 (3.4%)
Travel$81,128 (1.3%)
Royalty/License$41,451 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.6M | 516 | 41.9% |
| Unspecified | $2.4M | 102 | 37.9% |
| Space rental or facility fees (teaching hospital only) | $552,500 | 26 | 8.9% |
| Grant | $231,750 | 9 | 3.7% |
| Food and Beverage | $214,182 | 6,281 | 3.4% |
| Education | $134,200 | 16 | 2.2% |
| Travel and Lodging | $81,128 | 201 | 1.3% |
| Royalty or License | $41,451 | 8 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 0.0% |
| Entertainment | $206.41 | 6 | 0.0% |
Payments by Type
General
$3.9M
7,064 transactions
Research
$2.4M
102 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A MULTICENTER, PROSPECTIVE, RANDOMIZED, CONTROLLED, OPEN LABEL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF MYNX CONTROL VENOUS VASCULAR CLOSURE DEVICE 6F-12F VS. MANUAL COMPRESSION IN PATIENTS WHO HAVE UNDERGONE ENDOVASCULAR PROCEDURES UTILIZING UP TO 12F PROCEDURAL SHEATHS | $2.3M | 4 | 80 |
| A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF THE INCRAFT STENT GRAFT SYSTEM IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS | $26,323 | 0 | 11 |
| A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF THE INCRAFT STENT GRAFT SYSTEM IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS INSPIRATION | $21,726 | 0 | 11 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Christopher Lesar, M.d, M.D | Vascular Surgery | Chattanooga, TN | $5,610 | $0 |
| Ehrin Armstrong, M.d, M.D | Cardiovascular Disease | Englewood, CO | $4,979 | $0 |
| Kenneth Rosenfield, M.d, M.D | Cardiovascular Disease | Boston, MA | $4,918 | $0 |
| Dr. Daniel Simon, M.d, M.D | Diagnostic Radiology | New Brunswick, NJ | $4,756 | $0 |
| Dr. John Summers, M.d, M.D | Cardiovascular Disease | Oklahoma City, OK | $4,662 | $0 |
| Sudhakar Satti, Md, MD | Neuroradiology | Paoli, PA | $4,625 | $0 |
| Dr. John Carson, M.d, M.D | Surgery | Scarborough, ME | $4,599 | $0 |
| Timinder Biring, Md, MD | Cardiovascular Disease | Edina, MN | $4,500 | $0 |
| Robert Lookstein, Md, MD | Diagnostic Radiology | New York, NY | $4,474 | $0 |
| Amr El-Sergany, M.d, M.D | Vascular & Interventional Radiology | Aiea, HI | $4,401 | $0 |
| Juan Pastor-Cervantes, Md, MD | Interventional Cardiology | Hollywood, FL | $4,368 | $0 |
| Dr. Mark Rothenberg, Md, MD | Interventional Cardiology | Wellington, FL | $4,350 | $0 |
| Dr. Bret Wiechmann, Md, MD | Diagnostic Radiology | Gainesville, FL | $4,338 | $0 |
| Dr. Kintur Sanghvi, Md, MD | Internal Medicine | Bordentown, NJ | $4,282 | $0 |
| Dr. Ramzan Zakir, M.d, M.D | Nuclear Cardiology | New Brunswick, NJ | $4,163 | $0 |
| Dr. Jon George, Md, MD | Interventional Cardiology | Philadelphia, PA | $4,068 | $0 |
| John Wang, M.d, M.D | Cardiovascular Disease | Baltimore, MD | $4,033 | $0 |
| Dr. Garrett Wong, M.d, M.D | Interventional Cardiology | Sacramento, CA | $3,877 | $0 |
| Dr. Willis Wu, Md, MD | Cardiovascular Disease | Raleigh, NC | $3,875 | $0 |
| Prashant Kaul, M.d, M.D | Cardiovascular Disease | Atlanta, GA | $3,843 | $0 |
| Tony Das, Md, MD | Cardiovascular Disease | Dallas, TX | $3,830 | $0 |
| Dr. Darshan Doshi, M.d, M.D | Internal Medicine | Boston, MA | $3,754 | $0 |
| Pablo Guala, M.d, M.D | Cardiovascular Disease | Hialeah, FL | $3,660 | $0 |
| Dr. Arthur Lee, Md, MD | Interventional Cardiology | Gainesville, FL | $3,569 | $0 |
| Subbarao Mylavarapu, Md, MD | Cardiovascular Disease | Newport Beach, CA | $3,555 | $0 |
Ad
Top Products
- MYNX Venous VCD $2.3M
- MYNX CONTROL $116,881
Associated Products (20)
- MYNX Venous VCD $2.3M
- MYNX CONTROL $116,881
- BRITE TIP $80,611
- ANGIOGUARD $48,848
- Cardio $43,713
- S.M.A.R.T. $36,270
- SABER $31,415
- PRECISE PRO RX $31,329
- Angioguard $27,874
- NCRAFT AAA Stent Graft System $27,127
- SUPER TORQUE $22,242
- RADIAL 360 $21,986
- Mynx Venous VCD $21,680
- BRITE TIP RADIANZ $21,456
- RAIN SHEATH $19,111
- SELUTION SLRPTA $16,906
- MYNXGRIP $15,828
- SELUTION SLRPCTA $12,935
- Endo $10,542
- RAIN SHEATH TRANSRADIAL $10,007
Payment Categories
- Food & Beverage $214,182
- Consulting $2.6M
- Travel & Lodging $81,128
- Research $2.4M
- Royalties $41,451
About CORDIS US CORP.
CORDIS US CORP. has made $6.2M in payments to 3,284 healthcare providers, recorded across 7,166 transactions in the CMS Open Payments database. In 2024, the company paid $1.5M. The top product by payment volume is MYNX Venous VCD ($2.3M).
Payments were distributed across 85 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($2.2M to 667 doctors).
Payment categories include: Food & Beverage ($214,182), Consulting ($2.6M), Research ($2.4M), Travel & Lodging ($81,128), Royalties ($41,451).
CORDIS US CORP. is associated with 20 products in the CMS Open Payments database, including MYNX Venous VCD, MYNX CONTROL, and BRITE TIP.